Italy Pregabalin Market Outlook

the italy pregabalin market is highly promising and is expected to increase its market size significantly over the forecast period (2018-2032). pregabalin is an anticonvulsant and anti-epileptic drug used to treat various conditions such as neuropathic pain, generalized anxiety disorder, seizure disorders, and fibromyalgia. italy is one of the main manufacturers and consumers of the drug in europe, which has set the tone for the demand for pregabalin in the nation. the trend in the demand of pregabalin has been robust in recent years owing to increasing need for better treatments of neurological disorders among patients. rising prevalence of cognitive diseases and increasing number of treatments for the same has catalyzed more intake of pregabalin in the country, leading to increase in its demand. the italian government has also enhanced initiatives to increase access to treatment options among patients in the country, this has added to the momentum for increase in the use of pregabalin in the nation while also providing impetus to the pregabalin market growth. with increasing public healthcare expenditure in the nation for better healthcare, pregabalin market is expected to further expand in the coming years. further, rising penetration of pregabalin in the medical sector of the country is expected to drive the market. the approximate cost of pregabalin solutions is quite low, which has increased its accessibility among lower-income group of people, providing impetus to the market growth in the country. in addition, direct presence of several key market players in the country and several activities made to promote pregabalin therapies in the nation are expected to provide further impetus to the market. further, introduction of new therapeutics for neuropathic pain is expected to catalyze the growth of pregabalin market in the country. overall, the increased demand for pregabalin in the country is expected to lead to a steady growth of the market over the forecast period.